Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Thyroid Drug Recall Most Serious; GLP-1s and Vitamin Deficiency; New T1D Guidelines

(MedPage Today) -- The FDA designated Vitruvias Therapeutics' recall of a lot of 30-mg levothyroxine-liothyronine tablets (Thyroid Tablets) as Class I, its most serious classification. (USA Today) At least six major U.S. hospitals have shut down...

Thyroid Drug Recall Most Serious; GLP-1s and Vitamin Deficiency; New T1D Guidelines

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 29 September →